ProCHO5 powder supplement 2 Modified

GUDID 05407010125221

Lonza Verviers

Ex vivo cell culture medium

• Primary Device ID: 05407010125221
• NIH Device Record Key: 7035ac08-043c-4ec4-ab42-b07bdac284e6
• Commercial Distribution Discontinuation: 2024-02-06
• Commercial Distribution Status: Not in Commercial Distribution
• Brand Name: ProCHO5 powder supplement 2 Modified
• Version Model Number: BESP441SUP2F175
• Company DUNS: 370158847
• Company Name: Lonza Verviers
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: true
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: false
• Lot Batch: false
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: false
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: false
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	05407010125221 [Primary]

FDA Product Code

• JSK: Supplement, Culture Media

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2024-02-13
• Device Publish Date: 2024-02-05

Devices Manufactured by Lonza Verviers

• 05407010125733 - Buffer J_SUO-001_Module L - 1L Bag Samp: 2025-01-28
• 05407010125726 - NCTF Powder - 380g: 2025-01-16
• 05407010125665 - SF5-16 med. with Pluronic Biograde -Sup1: 2025-01-14
• 05407010125672 - SF5-16 med. with Pluronic Biograde -500L: 2025-01-14
• 05407010125689 - SF5-16 med. with Pluronic Biograde -Sup2: 2025-01-14
• 05407010125696 - SF5-16 med. with Pluronic Biograde -Sup1: 2025-01-14
• 05407010125702 - SF5-16 med. with Pluronic Biograde - 5L: 2025-01-14
• 05407010125719 - SF5-16 med. with Pluronic Biograde -Sup2: 2025-01-14